Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
Sun Pharmaceutical Industries Limited
Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Dilip Shantilal Shanghvi | MD & Chairman of the Board | 54.53M | N/D | 1955 |
| Mr. Kalyanasundaram Subramanian | Director of Corporate Development | 65.3M | N/D | 1954 |
| Mr. C. S. Muralidharan | Chief Financial Officer | 38.89M | N/D | 1963 |
| Mr. Davinder Singh | Executive Vice-President of Global Operations | N/D | N/D | N/D |
| Mr. Dheeraj Prasad Sinha BE | EVP & Chief Information Officer | N/D | N/D | 1971 |
| Mr. Nimish Desai | Head of Investor Relations | N/D | N/D | N/D |
| Mr. Anoop Deshpande | Company Secretary & Compliance Officer | N/D | N/D | N/D |
| Mr. Suresh Kumar Rai | Chief Human Resources Officer | N/D | N/D | N/D |
| Mr. Kirti Wardhaman Ganorkar | Chief Executive Officer of India Business | N/D | N/D | 1967 |
| Mr. Aalok Dilip Shanghvi | Executive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director | N/D | N/D | 1984 |
Descripción
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Gestión corporativa
La calificación ISS Governance QuickScore de Sun Pharmaceutical Industries Limited a partir del 1 de junio de 2024 es 2. Las puntuaciones principales son Auditoría: 6; Junta: 3; Derechos del accionista: 1; Compensación: 4.
